Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Translational Gastroenterology and Hepatology
|
May 8, 2024
Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379)
Khaldoun Almhanna, Rimini Breakstone, Alexander Raufi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 14, 2006
Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma
Howard Safran, Thomas Dipetrillo, Paul Akerman, et al.
American Journal of Clinical Oncology
|
November 7, 2014
Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study
Kimberly Perez, Howard Safran, William Sikov, et al.
Cancer
|
March 29, 2002
A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone
Wallace Akerley, James Butera, Terek Wehbe, et al.
The Journal of Biological Chemistry
|
February 8, 2003
ErbB2 degradation mediated by the co-chaperone protein CHIP
Pengcheng Zhou, Norvin Fernandes, Ingrid L Dodge, et al.
American Journal of Clinical Oncology
|
April 9, 2008
Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer
Howard Safran, Thomas Miner, Murray Resnick, et al.
American Journal of Clinical Oncology
|
April 26, 2021
A Pilot Study of Short-course Nivolumab and Low-dose Ipilimumab for Adjuvant Treatment of Melanoma: Brown University Oncology Research Group Trial, BrUOG 324
Maria Constantinou, Thomas J Miner, John M Vatkevitch, et al.
The American Journal of Surgical Pathology
|
February 28, 2015
A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling
Evgeny Yakirevich, Siraj M Ali, Anthony Mega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2019
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation
Timothy Kinsella, Howard Safran, Susan Wiersma, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 12, 2012
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study
Jeffrey M Hardacre, Mary Mulcahy, William Small, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Translational Gastroenterology and Hepatology
|
May 8, 2024
Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379)
Khaldoun Almhanna, Rimini Breakstone, Alexander Raufi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 14, 2006
Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma
Howard Safran, Thomas Dipetrillo, Paul Akerman, et al.
American Journal of Clinical Oncology
|
November 7, 2014
Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study
Kimberly Perez, Howard Safran, William Sikov, et al.
Cancer
|
March 29, 2002
A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone
Wallace Akerley, James Butera, Terek Wehbe, et al.
The Journal of Biological Chemistry
|
February 8, 2003
ErbB2 degradation mediated by the co-chaperone protein CHIP
Pengcheng Zhou, Norvin Fernandes, Ingrid L Dodge, et al.
American Journal of Clinical Oncology
|
April 9, 2008
Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer
Howard Safran, Thomas Miner, Murray Resnick, et al.
American Journal of Clinical Oncology
|
April 26, 2021
A Pilot Study of Short-course Nivolumab and Low-dose Ipilimumab for Adjuvant Treatment of Melanoma: Brown University Oncology Research Group Trial, BrUOG 324
Maria Constantinou, Thomas J Miner, John M Vatkevitch, et al.
The American Journal of Surgical Pathology
|
February 28, 2015
A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling
Evgeny Yakirevich, Siraj M Ali, Anthony Mega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2019
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation
Timothy Kinsella, Howard Safran, Susan Wiersma, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 12, 2012
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study
Jeffrey M Hardacre, Mary Mulcahy, William Small, et al.
Page
of 12